New brand drug - Otezla XR (apremilast)

Indicated for 1) psoriatic arthritis in adult and pediatric patients 6 years and older; 2) plaque psoriasis in adult patients; 3) moderate-severe plaque psoriasis in pediatric patients 6 years and older; and 4) Behcet disease-associated oral ulcers in adult patients.